ArticleBMC microbiology2026
Lactobacillus plantarum may prevent cholesterol gallstone formation by restoring gallbladder motility through preserving Cajal-like cells in mice.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundGallstone disease is closely linked to gallbladder dysmotility and gut microbiota dysbiosis; however, the specific role of Lactobacillus depletion in this pathogenesis remains unclear. This study investigated whether lithogenic diet (LD) induced cholesterol gallstone formation is associated with Lactobacillus deficiency and evaluated the potential of Lactobacillus plantarum (L. plantarum) supplementation to mitigate stone formation by restoring gallbladder motility. METHODS AND
resultsHere, we used a murine cholelithiasis model using C57BL/6 mice fed an HFD to characterize whether gallstone formation in relation to gut microbiota dysbiosis and gallbladder dysmotility. Lactobacillus depletion was identified as a hallmark of gallstone formation, which was concomitant with gallbladder dysmotility. To target this deficit, L. plantarum was administered via daily gavage in an intervention cohort. L. plantarum supplementation significantly inhibited stone formation and improved CCK-induced gallbladder emptying. Histologically, probiotic treatment preserved gallbladder wall architecture and recovered α-SMA and interstitial Cajal-like cells (CLCs) expression levels compared to controls. These findings suggest that Lactobacillus deficiency may contribute to LD-induced cholelithiasis by impairing gallbladder motility, and that L. plantarum supplementation effectively prevents stone formation by restoring the gut microbiota-gallbladder motility axis.
conclusionLD-induced gallstone formation is characterized by Lactobacillus depletion and gallbladder dysmotility driven by the loss of smooth muscle integrity and CLCs. Supplementation with L. plantarum effectively prevents gallstone formation likely by restoring impaired gallbladder contractility. These findings highlight Lactobacillus as a promising non-invasive therapeutic strategy to prevent gallstones.
Indexed as
Identifiers
42850587What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.